ClinVar Miner

Submissions for variant NM_000235.4(LIPA):c.974C>T (p.Pro325Leu)

gnomAD frequency: 0.00001  dbSNP: rs1326903845
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Alexion Pharmaceuticals, Inc RCV000857256 SCV000999845 likely pathogenic Lysosomal acid lipase deficiency 2019-06-01 criteria provided, single submitter research
PreventionGenetics, part of Exact Sciences RCV003411831 SCV004109187 uncertain significance LIPA-related condition 2023-03-14 criteria provided, single submitter clinical testing The LIPA c.974C>T variant is predicted to result in the amino acid substitution p.Pro325Leu. This variant was reported in one individual with lysosomal acid lipase deficiency participating in clinical trial (Del Angel et al. 2019. PubMed ID: 31180157). In vitro functional studies showed that this variant results in enzymatic activity of ab out 7-8% of wild type activity (Del Angel et al. 2019. PubMed ID: 31180157 Table S1). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.